Systemic Autoimmune Diseases
Systemic autoimmune diseases are disorders in which a misdirected immune response, marked by autoantibodies and immune-mediated tissue injury, affects multiple organ systems rather than a single tissue. In rheumatology this group includes systemic lupus erythematosus, systemic sclerosis, the inflammatory myopathies, Sjögren syndrome, and mixed connective tissue disease, which share overlapping clinical and serologic features while differing in their characteristic organ involvement.
Definition
Systemic autoimmune diseases are a category of autoimmune disorders characterized by adaptive immune responses against self-antigens that are not confined to one organ, producing circulating autoantibodies and inflammatory injury across several organ systems.
Scope
This area entry orients the reader to the shared concepts that unite the systemic connective tissue diseases: loss of immune tolerance, autoantibody profiles, multi-organ involvement, and overlapping clinical presentations. It links to the individual disease topics, which carry the detailed essentials. It is a reference-educational overview and not a source of diagnostic or treatment instructions.
Sub-topics
Key concepts
- Loss of immune self-tolerance
- Antinuclear and disease-specific autoantibodies
- Multi-organ (systemic) involvement
- Clinical and serologic overlap between diseases
- Type I interferon signature
- Classification versus diagnostic criteria
- Disease activity versus accrued damage
Mechanisms
The systemic autoimmune diseases share a breakdown of tolerance to self-antigens, often nuclear or nucleic-acid-associated, with production of autoantibodies such as antinuclear antibodies. Innate and adaptive immunity interact, and a type I interferon signature is prominent in lupus and related conditions, while distinct effector pathways shape the organ pattern of each disease: immune-complex deposition in lupus, vasculopathy and fibroblast activation in systemic sclerosis, muscle-directed inflammation in the myopathies, and exocrine-gland lymphocytic infiltration in Sjögren syndrome (Tsokos, 2011; Allanore et al., 2015; Mariette & Criswell, 2018; Dalakas, 2015). Specific autoantibody profiles correlate with particular clinical phenotypes across these diseases.
Clinical relevance
Because these diseases overlap clinically and serologically, they are usually considered together when a patient presents with multisystem features such as arthralgia, Raynaud phenomenon, cytopenias, or characteristic autoantibodies. The grouping helps frame how rheumatologic evaluation is structured and how classification criteria are used in research; it describes the conceptual landscape and is not a basis for individual diagnostic or therapeutic decisions.
Epidemiology
As a group the systemic autoimmune diseases are uncommon individually but collectively account for substantial chronic morbidity, and most show a marked female predominance. Their incidence and prevalence vary by disease, ancestry, and geography; the detailed figures are given in the individual topic entries.
Evidence & guidelines
Each disease in this group has classification criteria and management recommendations developed jointly by the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR, formerly the European League Against Rheumatism). These criteria standardize research populations rather than diagnose individuals, and are described in each topic entry.
History
The concept of systemic, as opposed to organ-specific, autoimmunity emerged in the twentieth century with the discovery of antinuclear antibodies and the LE cell, and was refined as serologic testing distinguished specific autoantibody patterns. Recognition that these diseases form an overlapping family, including the description of mixed connective tissue disease as a distinct overlap entity, shaped the modern grouping used in rheumatology.
Related topics
Seminal works
- tsokos-2011
- allanore-2015
- mariette-2018
- dalakas-2015
Frequently asked questions
- What makes an autoimmune disease 'systemic'?
- A systemic autoimmune disease involves immune-mediated injury across several organ systems and typically circulating autoantibodies, in contrast to organ-specific autoimmunity that targets a single tissue such as the thyroid or pancreas.
- Why are these diseases grouped together in rheumatology?
- They share mechanisms (loss of self-tolerance, autoantibody production) and overlapping clinical features, so they are evaluated and studied as a family, even though each has a characteristic pattern of organ involvement.